Basic Micardis Information

• INN (International Nonproprietary Name): Telmisartan (telmisartanum).
• Brand Names Available In Australia: Micardis (tablets 20 mg, 40 mg, 80 mg) by Boehringer Ingelheim and multiple generics; local packaging may include blister packs of 14, 28, 30 or 60 tablets.
• ATC Code: C09CA07 — Angiotensin II Receptor Blockers (ARBs), plain.
• Forms & Dosages: Oral tablets only; available strengths 20 mg, 40 mg and 80 mg; no creams, vials or liquid formulations reported in common clinical use.
• Manufacturers In Australia: Originator Boehringer Ingelheim plus generic suppliers such as Teva, Sandoz, Aurobindo, Cipla, Torrent, Macleods and others supplying Australian pharmacies.
• Registration Status In Australia: Prescription only (Rx) and approved by the Therapeutic Goods Administration (TGA).
• OTC / Rx Classification: Prescription Only (Rx) in all jurisdictions.

Latest Research Highlights

What does recent evidence say about telmisartan and ARBs?

Recent Australian and international evidence from 2022–2025 continues to support angiotensin receptor blockers as effective and well tolerated for long‑term blood pressure control and cardiovascular protection.

Meta‑analyses across 2022–2025 report consistent reductions in systolic blood pressure and lower risk of stroke and major cardiovascular events compared with untreated controls.

Telmisartan in particular showed non‑inferiority to ACE inhibitors on major clinical outcomes in several high‑risk trial cohorts.

Australian pharmacovigilance summaries from the TGA (2022–2025) confirm low rates of serious adverse events for telmisartan but ongoing signals for hyperkalaemia and renal‑function changes when RAAS agents are combined.

Primary‑care pharmacoepidemiology in recent years finds higher adherence with once‑daily ARBs, including telmisartan, than with twice‑daily antihypertensives.

Data Highlights

Clinical Effectiveness In Australia

Will telmisartan reliably lower blood pressure in everyday practice?

Telmisartan (Micardis and generics) is widely used across Australian primary care and specialist settings for stage 1–2 hypertension and long‑term cardiovascular risk reduction.

TGA approval and the availability of 20/40/80 mg tablets support routine prescribing in adults.

Real‑world PBS‑linked studies show target blood pressure is achieved in a high proportion of adherent patients taking telmisartan, helped by once‑daily dosing and minimal drug–food interaction.

TGA post‑marketing monitoring reinforces the need for renal and potassium checks after starting or changing dose, particularly in older Australians and those on other nephrotoxic medicines.

Indications And Expanded Uses

Who is telmisartan licensed for, and when might clinicians use it off‑label?

TGA‑approved indications match international labels: hypertension in adults and cardiovascular risk reduction in selected high‑risk adults, commonly those aged 55 years or older with vascular disease or diabetes.

Clinicians in Australia sometimes prescribe telmisartan off‑label for proteinuric chronic kidney disease or as an ACE inhibitor alternative when ACE inhibitors are not tolerated, but this is done case‑by‑case with close monitoring.

Telmisartan is available in single‑pill combinations with hydrochlorothiazide for patients requiring dual therapy.

• On‑Label Uses: Hypertension in adults; cardiovascular risk reduction for selected high‑risk patients.
• Off‑Label Uses (Case‑By‑Case): Proteinuric CKD under specialist supervision; ACE inhibitor intolerance substitute.

Checklist For Considering Telmisartan

• Adult patient with stage 1–2 hypertension.
• History of ACE inhibitor cough or intolerance.
• High cardiovascular risk patient aged ≥55 years being considered for risk reduction.
• Avoid as sole therapy for acute decompensated heart failure.

Composition And Brand Landscape

What are the formulations, and which brands supply telmisartan in Australia?

The active ingredient is telmisartan (INN: telmisartanum) and the ATC code is C09CA07.

Dosage forms in common clinical use are oral tablets of 20 mg, 40 mg and 80 mg strength, usually packaged in blisters of 14, 28, 30 or 60 tablets.

The originator product is Micardis (Boehringer Ingelheim) and a wide range of generics from suppliers such as Teva, Sandoz, Aurobindo, Cipla, Torrent and Macleods are available in Australia.

Contraindications And Special Precautions

Who should not take telmisartan and what precautions are important?

Absolute contraindications include known hypersensitivity to telmisartan or excipients, pregnancy (especially in the second and third trimesters), severe hepatic impairment with cholestasis or biliary obstructive disorders, and concomitant use with aliskiren in patients with diabetes or moderate–severe renal impairment.

Relative precautions apply to renal artery stenosis, baseline hyperkalaemia, severe renal impairment and the elderly who may be more sensitive to blood pressure‑lowering effects.

Special attention is required for Indigenous and remote communities with higher baseline rates of renal disease and diabetes; start low and monitor closely where indicated.

Daily Life Cautions

• Avoid heavy machinery or driving if dizziness occurs after starting or increasing dose.
• Counsel safety‑critical workers about orthostatic effects.

Pregnancy And Renal Warning

Telmisartan is contraindicated in pregnancy because of known fetal risk with RAAS‑acting drugs, and renal function and serum potassium should be checked after initiation or dose changes.

Dosage Guidelines

What dose should most adults start on and how should it be adjusted?

The usual starting dose for adult hypertension is 40 mg once daily, with titration up to 80 mg once daily as required.

For cardiovascular risk reduction in patients aged 55 years or older the commonly used target dose is 80 mg once daily.

Children: safety and efficacy are not established and routine use is not recommended.

Elderly patients do not routinely require an initial dose reduction but should have renal function monitored after starting or increasing dose.

Hepatic impairment: use a lower starting dose in mild to moderate hepatic disease and avoid in severe hepatic impairment.

Titration And Monitoring Algorithm

1. Start 40 mg once daily for most adults.
2. Recheck blood pressure and electrolytes within 1–2 weeks and again after dose changes.
3. If BP remains above target, increase to 80 mg once daily and repeat monitoring.

Interactions Overview

Which medicines increase the risk of harm when combined with telmisartan?

Avoid combining telmisartan with an ACE inhibitor or with aliskiren in patients with diabetes or moderate–severe renal impairment due to increased risk of renal injury and hyperkalaemia.

Concurrent use of potassium‑sparing diuretics, potassium supplements or potassium‑containing salt substitutes increases the risk of hyperkalaemia.

NSAIDs can blunt the antihypertensive effect of telmisartan and increase the risk of renal impairment when used together, particularly in dehydrated patients or those with existing kidney disease.

No significant food interactions have been reported and telmisartan is suitable for once‑daily dosing regardless of meals.

Alcohol may worsen orthostatic hypotension, while routine coffee intake has no clinically meaningful interaction.

Cultural Perceptions And Patient Habits

How do Australian patients feel about telmisartan and what affects adherence?

Australian patients generally prefer once‑daily, well‑tolerated medicines and this supports adherence to telmisartan regimens.

Price sensitivity is a strong driver for younger, low‑income and rural patients who often favour generics or discount retailers.

Pharmacists are widely trusted for medicine counselling and play a key role in adherence support, especially with telehealth and e‑prescriptions after COVID‑19.

Indigenous and remote communities face challenges with access and continuity, and Aboriginal health services commonly provide tailored counselling and monitoring.

Online forums and consumer reviews often note fewer cough issues versus ACE inhibitors and emphasise the desire for affordable generic Micardis options.

Availability And Pricing Patterns

Where can Australians buy micardis and how much does it typically cost?

Micardis and telmisartan generics are widely available through community pharmacies such as Chemist Warehouse, Priceline and TerryWhite Chemmart, hospital pharmacies and online pharmacies that accept telehealth e‑prescriptions.

Packaging usually comes in blisters of 14, 28, 30 or 60 tablets at strengths of 20 mg, 40 mg and 80 mg.

Some telmisartan formulations may be subsidised under the PBS for eligible patients, so check the PBS schedule for current listings and patient co‑payments.

Private prices at discount retailers vary considerably and patients commonly choose generics to reduce out‑of‑pocket cost.

Rural supply can sometimes be affected by short‑term stockouts of particular brands and community pharmacists often arrange therapeutic substitution to maintain continuity.

Checklist To Verify PBS Status

• Search the PBS schedule for telmisartan or Micardis brand listings.
• Ask your community pharmacist to confirm current subsidy and patient co‑payment.
• Confirm pack size and strength before purchase.

Comparable Medicines And Preferences

How does telmisartan compare with other ARBs and why might a prescriber choose it?

Telmisartan sits in the ARB class alongside losartan, valsartan, irbesartan and olmesartan, with broadly similar adverse‑effect profiles across the class.

Telmisartan provides once‑daily dosing and clinical evidence for cardiovascular risk reduction at 80 mg, which can favour it for long‑term prevention in selected patients.

Losartan is commonly chosen for certain CKD indications and has different pharmacology and dosing considerations, while valsartan and olmesartan are other alternatives with varying PBS coverage and generic availability.

Choice between ARBs in Australia is driven by comorbidities such as CKD or diabetes, prior ACE inhibitor intolerance, PBS coverage and local stock.

Pros And Cons Checklist

• Pros: Once‑daily dosing, well tolerated, available as generics and single‑pill combos with hydrochlorothiazide.
• Cons: Class risks of hyperkalaemia and renal effects with interacting drugs; some patients may prefer alternate ARBs for specific indications.

Frequently Asked Questions

Can I take telmisartan in pregnancy?

No — telmisartan is contraindicated in pregnancy, particularly in the second and third trimesters, because of risk to the fetus.

Are generics as effective as Micardis?

Yes — generics contain the same active ingredient telmisartan and are available in identical strengths (20 mg, 40 mg, 80 mg); check TGA approvals and PBS listings for specific products.

What if I miss a dose?

Take the missed dose as soon as you remember unless it is almost time for the next dose, and do not double up to make up a missed dose.

How quickly does telmisartan work?

Blood pressure lowering often begins within days, but maximal effect and appropriate titration are assessed over several weeks.

Guidelines For Proper Use

What should pharmacists cover when counselling patients starting telmisartan?

Counselling must include the indication, starting dose (usually 40 mg), titration plan to 80 mg if needed, and the expected time to effect over days to weeks.

Advise baseline and follow‑up monitoring of renal function and electrolytes (serum potassium) after initiation and after dose changes, especially if the patient uses interacting drugs.

Storage: keep tablets at room temperature (15–30°C) in original packaging to protect from moisture and light and avoid freezing.

Warn patients to seek urgent review for facial or tongue swelling, severe dizziness, fainting, new severe muscle pain or dark urine.

Adherence Tips

• Align dosing with a daily habit such as breakfast or tooth‑brushing time.
• Consider blister packs, dose organisers or pharmacy‑managed dose administration aids for older patients.
• Arrange PBS scripts or repeats where eligible to reduce cost barriers.

Monitoring Parameters

• Baseline blood pressure and regular home or clinic BP checks.
• eGFR and serum potassium at baseline, 1–2 weeks after starting or increasing dose, and periodically thereafter.
• Pregnancy test and contraception counselling for women of childbearing potential.

Sample Pharmacist Telehealth Script

"You are starting telmisartan 40 mg once daily for high blood pressure.

Please have a blood test for kidney function and potassium in 7–14 days and another check after any dose change.

If you experience dizziness, fainting or facial swelling, stop the medicine and seek urgent review."

Delivery Across Australia